ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
75.45
Bid
75.20
Ask
78.50
Volume
57,102
75.00 Day's Range 78.00
67.50 52 Week Range 93.80
Market Cap
Previous Close
78.35
Open
78.00
Last Trade
102
@
75.45
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
28,078
Shares Outstanding
40,400,000
Dividend Yield
-
PE Ratio
14.55
Earnings Per Share (EPS)
5.18
Revenue
964.3M
Net Profit
209.46M

About Melexis

Sector
Tire Retread & Repair Shops
Industry
Tire Retread & Repair Shops
Website
Headquarters
Mechelen, Antwerp, Bel
Founded
-
Melexis is listed in the Tire Retread & Repair Shops sector of the Euronext with ticker MELE. The last closing price for Melexis was 78.35 €. Over the last year, Melexis shares have traded in a share price range of 67.50 € to 93.80 €.

Melexis currently has 40,400,000 shares outstanding. The market capitalization of Melexis is 3.17 € billion. Melexis has a price to earnings ratio (PE ratio) of 14.55.

MELE Latest News

Melexis Q2 2024 résultats – Chiffre d'affaires de 245.7 millions d'euros au deuxième trimestre

Melexis Q2 2024 résultats – Chiffre d'affaires de 245.7 millions d'euros au deuxième trimestre Information réglementée Déclaration intermédiaire par le Conseil d'administrationYpres...

Melexis Q2 2024 results – Second quarter sales of 245.7 million EUR

Melexis Q2 2024 results – Second quarter sales of 245.7 million EUR Regulated information Intermediate declaration by the Board of Directors Ieper, Belgium - July 31st, 2024, 07.00 hrs CET Dear...

Melexis Q1 2024 results – First quarter sales of 241.8 million EUR

Melexis Q1 2024 results – First quarter sales of 241.8 million EUR Regulated information Intermediate declaration by the Board of Directors Ieper, Belgium - April 24th, 2024, 07.00 hrs CET...

Melexis Q4 et FY 2023 résultats – Chiffre d'affaires de 964.3 millions d'euros pour l’ensemble de l’année

Melexis Q4 et FY 2023 résultats – Chiffre d'affaires de 964.3 millions d'euros pour l’ensemble de l’année Information réglementée Déclaration intermédiaire par le Conseil...

Melexis Transparency Notification

Melexis Transparency Notification Press Release - Regulated information - Transparency notification Intermediate declaration by the Board of Directors Ypres, Belgium - November 20...

Changes to the Shareholding Structure

Changes to the Shareholding Structure Press Release - Regulated information - Inside information Intermediate declaration by the Board of Directors Ypres, Belgium - November 14, 2023, 19.00...

Melexis Q3 2023 results – Third quarter sales of 248.6 million EUR

Melexis Q3 2023 results – Third quarter sales of 248.6 million EUR Regulated information Intermediate declaration by the Board of Directors Ieper, Belgium - October 25th, 2023, 07.00 hrs CET...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.7-3.4548944337878.1578.65753680176.84458843DE
4-4.55-5.68758081.85752748078.02290822DE
12-4.65-5.8052434456980.186.6712807879.30952372DE
261.31.7532029669674.1587.269.63402279.14063847DE
52-5.1-6.3314711359480.5593.867.53542779.92349293DE
156-10.15-11.857476635585.6110.863.053243683.93632355DE
2604.86.794055201770.65110.843.863965978.18282449DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLSMLSmalto
0.018 €
(100.00%)
130.1k
MLPRXParx Materials NV
0.10 €
(66.67%)
36k
ALQGCQuantum Genomics
0.0295 €
(35.94%)
17.64M
CROSCrosswood
8.70 €
(16.00%)
14
ALMDTMedian Technologies
4.505 €
(12.63%)
513.52k
NAIWNew Amsterdam Invest NV
0.05 €
(-44.44%)
721
ALTROTronic s Microsystems
3.70 €
(-32.11%)
304
LIGLisgrafica
0.004 €
(-27.27%)
13.87k
MLUMGUmalis Group
1.37 €
(-19.41%)
33
ALAGOEPango SA
0.223 €
(-18.32%)
1.1M
BCPBanco Comercial Portugues SA
0.4189 €
(0.84%)
74.08M
ALNEVNeovacs
0.0006 €
(0.00%)
59.09M
ALTDTonner Drones
0.0082 €
(-14.58%)
24.89M
AGNAegon Ltd
5.61 €
(-0.43%)
23.84M
KPNKoninklijke KPN NV
3.626 €
(0.53%)
21.47M

Discussion

View Full Feed
Nelson2 Nelson2 2 minutes ago
Wonder why such high volume?

GLTA
BB
Vexari Vexari 2 minutes ago
In the beginning of a change

The patriot is a scarce man

And brave and hated and scorned

When his cause succeeds the timid join him

For then

It costs nothing

To be a patriot

~ Mark Twain ~
MJAM2020 MJAM2020 2 minutes ago
Yea been excited for a minute on this one... :) Not sure what you are referring to on the cellar boxing thing...attention spans are getting shorter and shorter these days...lol

Best of luck in your trades.

imho
mj
RNVA
The Whale The Whale 2 minutes ago
My bestie Shelly and I agree that $ICTY is the next copper bound baby.
ICTY
Mac1957 Mac1957 2 minutes ago
Linde must have a different feeling
PLUG
crazy horse 0 crazy horse 0 2 minutes ago
I hope he gets his

CAUGHT: NYC Covid Czar Admits Forcing Vaccines

https://www.youtube.com/watch?v=DulLO6C0Dik
DTGoody DTGoody 3 minutes ago
Addressing the controversy

https://youtu.be/fQvXBudt0OY
bluebird50 bluebird50 3 minutes ago
Fascinating posts and angles… ;-)
LEHNQ
The Whale The Whale 3 minutes ago
The buy was at .003

Don't chase, Chris.
DTGoody DTGoody 3 minutes ago
Addressing the controversy

https://youtu.be/fQvXBudt0OY
gfp927z gfp927z 3 minutes ago
Derf, Here's the quarterly results press release from CLMB (link below). The long term chart indicates they are doing something right, and market cap is still a miniscule $457 mil. The chart may need a pullback / consolidation before too long, but I'm figuring it's a worthy buy / hold for the lon
tat4tat tat4tat 4 minutes ago
June 7 2023 ... commitee formed to explore dual uplisting. They are on it they say ... sooner than later ... put some stank on it. Dont delete this as with other insightful posts of mine.
CEOS
DTGoody DTGoody 4 minutes ago
Addressing the controversy

https://youtu.be/fQvXBudt0OY
vuletini vuletini 4 minutes ago
Springfield duck.....don't knock it till you try it
XRPUSD
JOHNNIEBG JOHNNIEBG 4 minutes ago
Just big enough to hold a mushroom !!!!!
n4807g n4807g 5 minutes ago
BYD continues to pull away from the pack

https://insideevs.com/news/734623/byd-seagull-best-selling-china/?utm_source=Klaviyo&utm_medium=campaign&_kx=12wFdFU2yACIHXNEiG-QsKItdCqYwsrNEcSsJJoyaXI.VCGm8F
gimmegimmeminemine gimmegimmeminemine 5 minutes ago
In my line of work (and everyone else’s as well) you publicly trash talk a partner and that relationship takes a dramatic turn for the worse
I don't pay as much attention to what other companies say about KBLB. They are not responsible for promoting KBLB nearly as much as KBLB is.
KBLB
Risk vs Reward Risk vs Reward 6 minutes ago
Wish I had your buying power…

Money does make money …

We know what we have here ..

KULR
stealofadeal stealofadeal 6 minutes ago
$RDAR the scumbag CEO canceled the regulation a because he knew it was dead to the Stock. All he’s doing is issuing debt to his buddies now.
RDAR
LORTAP KCOTS LORTAP KCOTS 6 minutes ago
I was lucky too make a small gain on my shares yesterday. I’ll probably reload if it gets down a few more bucks
SNOW
Doc logic Doc logic 6 minutes ago
manibiotech,

Life and death decisions are being made by enforcement of “the process” and leaving patients no choice when they should have one. This is tantamount to homicide which some use “the process” to justify. However, when you run the numbers of patients who would be effective
BMY
tonyjh tonyjh 6 minutes ago
Never mind. This company is a short sellers wet dream. Just wait for the RS and go short. Easy money.
AWH
Itchy palm Itchy palm 7 minutes ago
Just saying I heard from a professional it would have to be a tiny 🍄 guillotine . 😂😁😂
BamaBreeze BamaBreeze 7 minutes ago
Sorry to hear that Oilin. I guess I have to give it to the bears too.
BLLB

Your Recent History

Delayed Upgrade Clock